India Tightens Grip on Diabetes and Obesity Drugs as Demand for GLP-1 Treatments Surges
India’s drug regulator has stepped up nationwide surveillance of GLP-1 medications, a class of drugs used to treat type 2 diabetes and obesity, ...
India’s drug regulator has stepped up nationwide surveillance of GLP-1 medications, a class of drugs used to treat type 2 diabetes and obesity, ...
A recent study by the Indian Council of Medical Research (ICMR) has uncovered a growing health concern in Indian households: nearly one in ...
After Swachh Bharat Abhiyan, which was elevated to a mass movement, Prime Minister Narendra Modi has now taken upon himself the task to ...
In recent years, India has witnessed a concerning surge in obesity rates, particularly among women and children. The implications of this trend are ...
In recent years, medical professionals have been witnessing a surprising development. The number of patients with fatty liver disease is on the rise. ...
According to WHO, there are more than one billion obese people around the world. As per another study, about 2 billion people are ...


©2026 TFI Media Private Limited